Diabetes Mellitus
Conditions
Keywords
Diabetes, Information Technology, Health Plans
Brief summary
The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.
Detailed description
Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.
Interventions
Automated Telephone Outreach with Speech Recognition
OTHERUsual Care
Usual Care
Sponsors
American Diabetes Association
Harvard Pilgrim Health Care
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age 18 years or older * Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes. * Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)
Exclusion criteria
* No primary care clinician in the data base * Those who had previously asked the health plan to exclude them from research or quality improvement * Women whose claim records contained diagnoses suggesting gestational diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Completion of dilated eye examination | 12-months following intervention |
Secondary
| Measure | Time frame |
|---|---|
| Completion of glycated hemoglobin testing (HbA1c) | one-year following intervention |
| Completion of LDL-cholesterol testing | one year following intervention |
| Completion of microalbumin testing | one-year following intervention |
Countries
United States
Outcome results
None listed